Weighted Average Number of Shares Outstanding, Basic of Akari Therapeutics Plc from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Akari Therapeutics Plc quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Akari Therapeutics Plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 65,326,236,698, a 168% increase year-over-year.
  • Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 23,888,010,485, a 144% increase from 2023.
  • Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 9,788,980,193, a 55168% increase from 2022.
  • Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 17,711,842, a 100% decline from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Akari Therapeutics Plc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 65,326,236,698 +40,940,231,175 +168% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 62,943,895,665 +44,107,416,688 +234% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 54,588,283,841 +41,135,135,862 +306% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 23,888,010,485 +14,099,030,292 +144% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 24,386,005,523 +14,269,101,925 +141% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 18,836,478,977 +18,816,224,859 +92901% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 13,453,147,979 +5,978,601,226 +80% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 9,788,980,193 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 10,116,903,598 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 20,254,118 -5,914,663,005 -100% 01 Apr 2023 30 Jun 2023 8-K 06 Sep 2024
Q1 2023 7,474,546,753 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q2 2022 5,934,917,123 +2,087,564,737 +54% 01 Apr 2022 30 Jun 2022 6-K 27 Sep 2022 2022 Q2
Q2 2021 3,847,352,386 01 Apr 2021 30 Jun 2021 6-K 27 Sep 2022 2022 Q2
Q2 2019 1,607,121,984 +81,428,591 +5.3% 01 Apr 2019 30 Jun 2019 6-K 29 Aug 2019 2019 Q2
Q2 2018 1,525,693,393 +348,000,010 +30% 01 Apr 2018 30 Jun 2018 6-K 29 Aug 2019 2019 Q2
Q2 2017 1,177,693,383 0 0% 01 Apr 2017 30 Jun 2017 6-K 27 Sep 2018 2018 Q2
Q2 2016 1,177,693,383 01 Apr 2016 30 Jun 2016 6-K 10 Aug 2017 2017 Q2
Q1 2016 1,177,693,383 +455,347,783 +63% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q3 2015 781,738,789 +708,368,522 +965% 01 Jul 2015 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q1 2015 722,345,600 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q3 2014 73,370,267 01 Jul 2014 30 Sep 2014 10-Q 23 Nov 2015 2015 Q3

Akari Therapeutics Plc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 23,888,010,485 +14,099,030,292 +144% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 9,788,980,193 +9,771,268,351 +55168% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 17,711,842 -4,274,400,825 -100% 01 Jan 2022 31 Dec 2022 8-K 06 Sep 2024
2021 4,292,112,667 +1,133,075,079 +36% 01 Jan 2021 31 Dec 2021 20-F 01 May 2023 2022 FY
2020 3,159,037,588 +1,328,038,979 +73% 01 Jan 2020 31 Dec 2020 20-F 01 May 2023 2022 FY
2019 1,830,998,609 +290,688,769 +19% 01 Jan 2019 31 Dec 2019 20-F 16 May 2022 2021 FY
2018 1,540,309,840 +293,016,452 +23% 01 Jan 2018 31 Dec 2018 20-F 21 Apr 2021 2020 FY
2017 1,247,293,388 +69,600,005 +5.9% 01 Jan 2017 31 Dec 2017 20-F 31 Mar 2020 2019 FY
2016 1,177,693,383 +325,604,853 +38% 01 Jan 2016 31 Dec 2016 20-F 23 Apr 2019 2018 FY
2015 852,088,530 +766,572,942 +896% 01 Jan 2015 31 Dec 2015 20-F 18 Jul 2018 2017 FY
2014 85,515,588 +64,440,523 +306% 01 Jan 2014 31 Dec 2014 20-F 31 Mar 2017 2016 FY
2013 21,075,065 +8,616,191 +69% 01 Jan 2013 31 Dec 2013 10-K 11 Feb 2015 2014 FY
2012 12,458,874 01 Jan 2012 31 Dec 2012 10-K 11 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.